Joey L. Methot

Statistics

Publications

Citations

1.8K

H-Index

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Quantitative BioSciences

United States Military Academy

University of Michigan

Joey L. Methot is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2003–2024

Publications

Nucleophilic Phosphine Organocatalysis

Joey L. Methot, William Roush · Advanced Synthesis & Catalysis · 2004 · 969 citations · Full text

Natural Sciences, Chemistry, Catalysis +14

Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)

Joey L. Methot, Prasun K. Chakravarty, Mélissa Chénard et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 187 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +10

Synthetic Studies toward FR182877. Remarkable Solvent Effect in the Vinylogous Morita−Baylis−Hillman Cyclization

Joey L. Methot, William Roush · Organic Letters · 2003 · 79 citations

Natural Sciences, Chemistry, Medicinal Chemistry +16

Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds

Brandon Vara, Samuel M. Levi, Abdelghani Achab et al. · ACS Medicinal Chemistry Letters · 2021 · 50 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities

Andrea Newbold, Geoffrey M. Matthews, Michael Bots et al. · Molecular Cancer Therapeutics · 2013 · 46 citations

Medicine, Oncology, Pharmacology +17

1–5 of 25